IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,325 | +18.0% | 216,782 | +23.3% | 0.13% | -5.8% |
| Q4 2022 | $1,123 | -99.9% | 175,793 | +117.6% | 0.14% | +35.0% |
| Q3 2022 | $774,000 | -60.8% | 80,776 | -54.8% | 0.10% | -65.2% |
| Q2 2022 | $1,972,000 | +604.3% | 178,578 | +961.5% | 0.30% | +678.9% |
| Q1 2022 | $280,000 | -4.8% | 16,823 | +9.3% | 0.04% | +2.7% |
| Q4 2021 | $294,000 | +19.0% | 15,398 | +189.4% | 0.04% | -7.5% |
| Q4 2020 | $247,000 | +81.6% | 5,321 | -62.7% | 0.04% | +185.7% |
| Q1 2019 | $136,000 | -43.1% | 14,266 | -47.2% | 0.01% | -50.0% |
| Q4 2018 | $239,000 | – | 27,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |